Name: Inhibrx Biosciences, Inc. (INBX) Cash Flow Statement
Creator: FinSpry

Inhibrx Biosciences Cash Flow Statement Analysis

Operating, investing, and financing activities in billions USD

Scale:

Scroll to see more

Cash flow statement showing operating, investing, and financing activities for Inhibrx Biosciences, Inc. (INBX) - Annual data in billions USD
Breakdown	FY 2024	FY 2023	FY 2022
Period Ending	Dec 2024	Dec 2023	Dec 2022
Operating Activities
Net Income	1.69	-0.24	-0.12
Depreciation & Amortization	0.00	0.00	0.00
Stock Based Compensation	0.06	0.02	0.02
Change in Working Capital	0.05	0.02	0.00
Change in Accounts Receivable	0.00	0.00	0.00
Change in Accounts Payable	0.02	0.00	0.00
Change in Other Working Capital	0.00	0.01	0.00
Other Operating Activities	0.00	0.01	0.00
Net Cash from Operating Activities	-0.19	-0.19	-0.09
Investing Activities
Capital Expenditures	0.00	0.00	0.00
Net Cash from Investing Activities	0.00	0.00	0.00
Financing Activities
Common Stock Issued	0.07	0.20	0.00
Other Financing Activities	0.00	0.00	0.09
Net Cash from Financing Activities	0.07	0.20	0.09
Summary
Net Change in Cash	-0.13	0.00	0.00
Cash at Beginning of Period	0.28	0.27	0.00
Cash at End of Period	0.15	0.28	0.00
Free Cash Flow	-0.20	-0.20	-0.09
Supplemental Disclosures
Interest Paid	0.01	0.03	0.00
Income Taxes Paid	0.00	0.00	0.00